Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal H G Duijf

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Biology|November 26, 2002
A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanismZach Serber, Helen C Lai, Annie Yang, et al.
Expert Opinion on Therapeutic Targets|March 17, 2020
Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemnessBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Cell Death & Disease|November 8, 2019
A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescenceNadine H Brückmann, Sofie N Bennedsen, Pascal H G Duijf, et al.
International Journal of Oral Science|February 17, 2024
A novel saliva-based miRNA profile to diagnose and predict oral cancerJaikrishna Balakittnen, Chameera Ekanayake Weeramange, Daniel F Wallace, et al.
Communications Biology|October 22, 2020
Cep55 overexpression promotes genomic instability and tumorigenesis in miceDebottam Sinha, Purba Nag, Devathri Nanayakkara, et al.
Human Molecular Genetics|March 28, 2008
A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromesTuula Rinne, Suzanne E Clements, Evert Lamme, et al.
NAR Cancer|September 27, 2021
Correction to 'Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer'Adrian P Wiegmans, Ambber Ward, Ekaterina Ivanova, et al.
NAR Cancer|July 28, 2021
Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancerAdrian P Wiegmans, Ambber Ward, Ekaterina Ivanova, et al.
Nature Communications|January 25, 2020
Chromosome arm aneuploidies shape tumour evolution and drug responseAnkit Shukla, Thu H M Nguyen, Sarat B Moka, et al.
Communications Biology|May 29, 2021
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapyKatrina Kildey, Neha S Gandhi, Katherine B Sahin, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Biology|November 26, 2002
A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanismZach Serber, Helen C Lai, Annie Yang, et al.
Expert Opinion on Therapeutic Targets|March 17, 2020
Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemnessBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Cell Death & Disease|November 8, 2019
A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescenceNadine H Brückmann, Sofie N Bennedsen, Pascal H G Duijf, et al.
International Journal of Oral Science|February 17, 2024
A novel saliva-based miRNA profile to diagnose and predict oral cancerJaikrishna Balakittnen, Chameera Ekanayake Weeramange, Daniel F Wallace, et al.
Communications Biology|October 22, 2020
Cep55 overexpression promotes genomic instability and tumorigenesis in miceDebottam Sinha, Purba Nag, Devathri Nanayakkara, et al.
Human Molecular Genetics|March 28, 2008
A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromesTuula Rinne, Suzanne E Clements, Evert Lamme, et al.
NAR Cancer|September 27, 2021
Correction to 'Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer'Adrian P Wiegmans, Ambber Ward, Ekaterina Ivanova, et al.
NAR Cancer|July 28, 2021
Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancerAdrian P Wiegmans, Ambber Ward, Ekaterina Ivanova, et al.
Nature Communications|January 25, 2020
Chromosome arm aneuploidies shape tumour evolution and drug responseAnkit Shukla, Thu H M Nguyen, Sarat B Moka, et al.
Communications Biology|May 29, 2021
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapyKatrina Kildey, Neha S Gandhi, Katherine B Sahin, et al.
Pageof 8